The iron maiden: Oligodendroglial metabolic dysfunction in multiple sclerosis and mitochondrial signaling

Area of Science:

• Neuroimmunology
• Neurobiology
• Mitochondrial Biology

Background:

• Multiple sclerosis (MS) is a CNS autoimmune disease characterized by oligodendrocyte (OL) dysfunction and demyelination, leading to neurological deficits.
• Mitochondria play a key role in myelin biogenesis, supporting the energy demands of the axo-glial unit.
• Thyroid hormone (TH) transport into the CNS is vital for OL maturation, myelination, and maintaining metabolic pathways for myelin synthesis.

Purpose of the Study:

• To investigate the role of TH-dependent mechanisms in OL function and myelin maintenance within the CNS.
• To explore how TH deficits impact mitochondrial efficiency and metabolic pathways crucial for myelination in MS.
• To understand the link between TH dysregulation, impaired lipid biosynthesis, and ferroptosis in MS-related neurodegeneration.

Main Methods:

• Analysis of TH transport and its influence on OL maturation and myelination.
• Investigation of mitochondrial function and metabolic pathways (acetyl-CoA, iron metabolism) in OLs.
• Examination of TH-dependent transcriptional and metabolic dysregulation in MS lesions.

Main Results:

• Deficits in TH regulatory functions contribute to oligodendrocytopathy, demyelination, and neurodegeneration.
• TH pathway dysregulation in MS lesions impairs acetyl-CoA production for myelin lipid biosynthesis.
• Altered iron metabolism driven by TH deficits may promote ferroptosis, exacerbating neurodegeneration.

Conclusions:

• TH-dependent pathways are critical for maintaining OL health and myelin integrity in the CNS.
• Dysfunctional TH signaling and mitochondrial impairment in MS contribute to demyelination and neurodegenerative processes.
• Targeting TH-dependent metabolic and iron regulatory mechanisms may offer therapeutic strategies for MS.